Image Credit: Love Employee / Shutterstock In a recent observational study published online as an unedited 'Article in Press' in the journal Scientific Reports , researchers at the University of California, San Francisco, reported that semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA) used to treat type 2 diabetes and manage weight in people with obesity or overweight, was associated with a lower hazard of coronavirus disease 2019 (COVID-19)-related death, consistent with previous findings
With the rise of GLP-1 medications like Ozempic, Wegovy, and Mounjaro, many people are experiencing significant fat loss
This amino acid-like compound, known for its role in energy production and fat metabolism, is available in various formulations, each with its own set of characteristics
Helpful context before the funnel FormBlends Editorial Context Reviewed May 14, 2026 Eden Health vs TrimRx comparison
However, discussion of these uses is beyond the scope of this article